ORKA Dividend History & Analysis | N/A Yield

ORKA has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

Yield 12m -
Payout Ratio -
Growth Rate CAGR 5y -100.00%
Consistency Lifetime 2.5%
Yield on Cost 5y -
Payout FCF -
Streak Years -
Dividend Rating 1.00%

Dividends Cash Amount per Share Yearly

This chart shows the yearly cash amount paid as dividends per share. The exact values for each year can be found in the structured dataset with the html-id #yearly_dividend_dataset below.
Dividend Growth Year over Year This chart shows the annual dividend growth rate compared to the previous year.
5 Years Chart with Price and Dividend Yield This chart shows the dividend yield and price over time. Price is displayed as gray area (left axis), yield as dark blue line (right axis), and average yield as orange dashed line.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap USD Dividend Yield TTM Yield on Cost 5y
ABBV 387,093 M 3.34% 7.76%
AMGN 198,244 M 3.21% 6.0%
GILD 176,133 M 2.79% 5.72%
HLN 46,623 M 1.76% 2.46%
BIM 13,657 M 0.74% 0.75%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap USD Growth Rate Consistency
BTX 1,397 M 134% 95.6%
HLN 46,623 M 30.1% 100%
AMGN 198,244 M 7.84% 100%
BIM 13,657 M 9.76% 96.0%
ABBV 387,093 M 5.98% 100%

Quality Dividend Peers in Biotechnology

AMGN
Amgen
3.21% Yield
GILD
Gilead Sciences
2.79% Yield

ORKA Dividend History: Last 1 Payments (USD) as of February 2026

Ex-Dividend Date Record Date Payment Date Period Dividend per Share Dividend Growth Rate QoQ Payout Yield
2024-08-29 2024-08-26 2024-08-28 Other 1.613 0% 85.34%

ORKA Dividend FAQ

Oruka Therapeutics (NASDAQ: ORKA) is a clinical-stage biotech headquartered in Menlo Park, CA, developing monoclonal antibodies for psoriasis and broader inflammatory-immunology indications. Its pipeline includes ORKA-001 (IL-23 p19 inhibitor) in a Phase 1 trial, ORKA-002 (dual IL-17A/F blocker) targeting psoriasis, psoriatic arthritis and other diseases, ORKA-003 (undisclosed target), and ORKA-021, a planned sequential combination of ORKA-001 and ORKA-002.

What is the Dividend Yield of ORKA?

As of February 2026, ORKA`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - USD by the current share price of 33.26.

Does ORKA pay a dividend?

As of February 2026 ORKA does not pay a dividend.

How often does ORKA pay dividends?

Over the last 12 months, ORKA has issued 0 dividend payments. The last dividend payment was made on 2024-08-29.

ORKA dividend forecast

Based on historical data, the forecasted dividends per share for ORKA for the next 4 payments are between 0 (-100.0%) and 0 (-100.0%).
This represents a significant dividend cut compared to the last payment.

Will ORKA pay dividends in 2026?

The latest dividend paid per share was 1.613 USD with an Ex-Dividend Date of 2024-08-29. The next Ex-Dividend date for Oruka Therapeutics (ORKA) is currently unknown.

What is the next Ex-Dividend Date for ORKA?

The next Ex-Dividend date for Oruka Therapeutics (ORKA) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of ORKA?

ORKA's average dividend growth rate over the past 5 years is -100% per year.
Negative growth: ORKA's Dividend growth is negative and declining.

What is the Yield on Cost of ORKA?

ORKA's 5-Year Yield on Cost is -%. If you bought ORKA's shares at 34.21 USD five years ago, your current annual dividend income (- USD per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of ORKA?

ORKA Payout Consistency is 2.5%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Very unstable: Oruka Therapeutics has a poor track record of dividend payments over its lifetime.

Does ORKA have a good Dividend Yield?

ORKA`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of ORKA?

The Dividend Payout Ratio of ORKA is unknown.

What is the Dividend Rating of ORKA?

ORKA`s Overall Dividend Rating is 1.00%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

ORKA Outstanding Shares Analysis

What is the Trend in ORKA's Outstanding Shares?

Oruka Therapeutics's outstanding shares have increased by approximately 74.84% annually over the past 3 years (Trend Reliability: 100.0%).

Significant dilution: Heavy share issuance is diluting existing shareholders. Even if total dividends paid increase, your dividend per share may stagnate or decline.

Has ORKA ever had a Stock Split?

Yes, the last stock split was on Sep 3, 2024 with a ratio of 1:12.

This was a reverse split: Multiple shares were consolidated into fewer shares, increasing the price per share. This is sometimes used to meet exchange listing requirements and can be a warning sign if the company is struggling.

Year Number of Shares Annual Growth Rate
2017 54,500
2018 64,500 +18.35%
2019 132,800 +105.89%
2020 795,700 +499.17%
2021 1,200,800 +50.91%
2022 1,200,800
2023 14,415,900 +1100.52%
2024 16,789,400 +16.46%
2025 44,067,100 +162.47%

Key Metric Definitions

Dividend Yield
Annual dividend per share divided by current share price.
Payout Ratio
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Payout FCF
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Growth Rate (CAGR)
Compound annual growth rate of dividends over the last 5 years.
Consistency
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Yield on Cost
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Streak
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Dividend Rating
Proprietary score (0-100) combining yield, growth, safety and consistency.

Last update: 2026-02-03 04:22